0001367644-21-000075.txt : 20210511 0001367644-21-000075.hdr.sgml : 20210511 20210511161825 ACCESSION NUMBER: 0001367644-21-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210510 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULLIVAN LOUIS W CENTRAL INDEX KEY: 0001193522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 21911552 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN LOUIS DATE OF NAME CHANGE: 20020927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_162076428587593.xml FORM 4 X0306 4 2021-05-10 0 0001367644 Emergent BioSolutions Inc. EBS 0001193522 SULLIVAN LOUIS W 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2021-05-10 4 M 0 10305 18.64 A 43063 D Common Stock 2021-05-10 4 F 0 3118 61.62 D 39945 D Employee Stock Options (Right to Buy) 18.64 2021-05-10 4 M 0 10305 0 D 2017-05-21 2021-05-21 Common Stock 10305.0 0 D Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock option exercise. Consists of an option granted under the company's stock incentive plan as amended and restated. The option vested in three equal installments in May 2015, May 2016 and May 2017. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. /s/ Scott Lieberman, Attorney-in-fact 2021-05-11